Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 64, Issue 12, 2012, Pages 4040-4047

  Kalunian, Kenneth C ^a   Chatham, W Winn ^b   Massarotti, Elena M ^c   Reyes Thomas, Joyce ^d   Harris, Cole ^e   Furie, Richard A ^f   Chitkara, Puja ^g   Putterman, Chaim ^d   Gross, Rachel L ^d   Somers, Emily C ^h   Kirou, Kyriakos A ⁱ   Ramsey Goldman, Rosalind ^j   Hsieh, Christine ^j   Buyon, Jill P ^k   Dervieux, Thierry ^e   Weinstein, Arthur ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Exagen Diagnostics Inc   (United States)

^f DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

^g San Diego Arthritis Medical Clinic   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ HOSPITAL FOR SPECIAL SURGERY   (United States)

^j NORTHWESTERN UNIVERSITY   (United States)

^k NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l WASHINGTON HOSPITAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT COMPONENT C4D; DNA ANTIBODY; VIMENTIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CALCULATION; CELL SELECTION; COMPLEMENT ACTIVATION; CROSS-SECTIONAL STUDY; DERMATOMYOSITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FIBROMYALGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITIVE INDEX SCORE; PRIORITY JOURNAL; RATING SCALE; RHEUMATIC DISEASE; SENSITIVITY AND SPECIFICITY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTI-IDIOTYPIC; ANTIBODIES, ANTINUCLEAR; B-LYMPHOCYTES; BIOLOGICAL MARKERS; BLOOD PLATELETS; CASE-CONTROL STUDIES; COMPLEMENT ACTIVATION; COMPLEMENT C4B; CROSS-SECTIONAL STUDIES; DNA; ERYTHROCYTES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PEPTIDE FRAGMENTS; RECEPTORS, COMPLEMENT; SENSITIVITY AND SPECIFICITY; VIMENTIN;

EID: 84870318105     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34669     Document Type: Article

References (21)

1. Rahman A, Isenberg DA,. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-39. (Pubitemid 351397092)
2. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al, for the National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum 2008; 58: 15-25.
3. Bastian HM, Roseman JM, McGwin G Jr, Alarcon GS, Friedman AW, Fessler BJ, et al. Systemic lupus erythematosus in three ethnic groups. XII. Risk factors for lupus nephritis after diagnosis. Lupus 2002; 11: 152-60. (Pubitemid 34296930)
4. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7. (Pubitemid 13221242)
5. Smith EL, Shmerling RH,. The American College of Rheumatology criteria for the classification of systemic lupus erythematosus: strengths, weaknesses, and opportunities for improvement. Lupus 1999; 8: 586-95. (Pubitemid 29520523)
6. Egner W,. The use of laboratory tests in the diagnosis of SLE. J Clin Pathol 2000; 53: 424-32. (Pubitemid 30396463)
7. Manderson AP, Botto M, Walport MJ,. The role of complement in the development of systemic lupus erythematosus. Annu Rev Immunol 2004; 22: 431-56. (Pubitemid 38680429)
8. Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, et al. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. Arthritis Rheum 2004; 50: 3596-604. (Pubitemid 39488685)
9. Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum 2006; 54: 670-4. (Pubitemid 43228646)
10. Yang DH, Chang DM, Lai JH, Lin FH, Chen CH,. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2009; 48: 1083-7.
11. Liu CC, Kao AH, Hawkins DM, Manzi S, Sattar A, Wilson N, et al. Lymphocyte-bound complement activation products as biomarkers for diagnosis of systemic lupus erythematosus. Clin Transl Sci 2009; 2: 300-8.
12. Kao AH, Navratil JS, Ruffing MJ, Liu CC, Hawkins D, McKinnon KM, et al. Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus. Arthritis Rheum 2010; 62: 837-44.
13. Batal I, Liang K, Bastacky S, Kiss LP, McHale T, Wilson NL, et al. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study. Lupus 2012; 21: 13-26.
14. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
15. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, et al, for the OC-SELENA Trial. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005; 353: 2550-8. (Pubitemid 41785892)
16. Furie R, Petri M, Zamani O, Cervera R, Wallace DJ, Tegzova D, et al, for the BLISS-76 Study Group. A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus. Arthritis Rheum 2011; 63: 3918-30.
17. Bang H, Egerer K, Gauliard A, Luthke K, Rudolph PE, Fredenhagen G, et al. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis. Arthritis Rheum 2007; 56: 2503-11. (Pubitemid 47237269)
18. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 2011; 12: 77.
19. Agresti A, Coull BA,. Approximate is better than "exact" for interval estimation of binomial proportions. Am Statist 1998; 52: 119-26.
20. Steyerberg E, Ewout W,. Clinical prediction models: a practical approach to development, validation and updating. New York: Springer-Verlag; 2009.
21. Singh V, Mahoney JA, Petri M,. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus. J Rheumatol 2008; 35: 1989-93.